Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-27

Clinical Trial Update: Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment [Phase 1]

View source ↗

Summary

Phase 1 trial update on a drug interaction study between ribavirin and abacavir in male hepatitis C patients who previously failed ribavirin treatment; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ribavirin (ribavirin)
  • abacavir (abacavir)

Snippet

Sponsor: Johns Hopkins University | Conditions: Hepatitis C, HIV | Phase 1 | Status: COMPLETED | Results posted: 2017-04-27